改变治疗局限性前列腺癌的时间

R. Kirby, P. Dasgupta
{"title":"改变治疗局限性前列腺癌的时间","authors":"R. Kirby, P. Dasgupta","doi":"10.1002/TRE.91","DOIUrl":null,"url":null,"abstract":"With recent NICE guidance emphasising the role of active surveillance for men with ‘low-risk’ prostate cancer, the authors ask whether we can reliably identify those men with cancers that have a minimal risk of progression. While it is important for patients to be involved in treatment decisions, the diversity of opinion and the lack of high quality comparative data mean that there is no recommended ‘best practice’ for treatment of this disease. Copyright © 2008 Wiley Interface Ltd","PeriodicalId":178319,"journal":{"name":"Trends in Urology, Gynaecology & Sexual Health","volume":"95 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2008-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Changing times for the management of localised prostate cancer\",\"authors\":\"R. Kirby, P. Dasgupta\",\"doi\":\"10.1002/TRE.91\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"With recent NICE guidance emphasising the role of active surveillance for men with ‘low-risk’ prostate cancer, the authors ask whether we can reliably identify those men with cancers that have a minimal risk of progression. While it is important for patients to be involved in treatment decisions, the diversity of opinion and the lack of high quality comparative data mean that there is no recommended ‘best practice’ for treatment of this disease. Copyright © 2008 Wiley Interface Ltd\",\"PeriodicalId\":178319,\"journal\":{\"name\":\"Trends in Urology, Gynaecology & Sexual Health\",\"volume\":\"95 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Trends in Urology, Gynaecology & Sexual Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/TRE.91\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Urology, Gynaecology & Sexual Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/TRE.91","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

最近NICE的指南强调了积极监测“低风险”前列腺癌男性的作用,作者提出了一个问题,我们是否能够可靠地识别出那些癌症进展风险最小的男性。虽然患者参与治疗决策很重要,但意见的多样性和缺乏高质量的比较数据意味着没有推荐的治疗这种疾病的“最佳做法”。版权所有©2008威利接口有限公司
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Changing times for the management of localised prostate cancer
With recent NICE guidance emphasising the role of active surveillance for men with ‘low-risk’ prostate cancer, the authors ask whether we can reliably identify those men with cancers that have a minimal risk of progression. While it is important for patients to be involved in treatment decisions, the diversity of opinion and the lack of high quality comparative data mean that there is no recommended ‘best practice’ for treatment of this disease. Copyright © 2008 Wiley Interface Ltd
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信